VIENNA, Oct. 16, 2025 /PRNewswire/ -- Lexogen, a leader in RNA sequencing technologies, announces the launch of the miRVEL Profiling Small RNA-Seq Library Prep Kit, designed to facilitate small RNA ...

Learn quick stock analysis for beginners. Discover how to pick stocks, compare companies, and build a winning investment portfolio in just 5 minutes! New video of Charlie Kirk shooting suspect ...

Essentially all cells in an organism's body have the same genetic blueprint, or genome, but the set of genes that are actively expressed at any given time in a cell determines what type of cell it ...

3 Transplantation Center, The Third Xiangya Hospital, Central South University, Changsha, China Background Acute-on-chronic liver failure (ACLF) is a life-threatening syndrome involving dysfunction of ...

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease ...

Introduction: RNA sequencing (RNA-seq) can measure whole transcriptome gene expression from tissues or even individual cells, providing a powerful tool to study the immune response. Analysis of ...

Financial statements can be intimidating to evaluate, so I will simplify the process in this video explainer. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the ...

LangGraph is a powerful framework by LangChain designed for creating stateful, multi-actor applications with LLMs. It provides the structure and tools needed to build sophisticated AI agents through a ...

This repository contains the RNA-seq analysis pipeline for validating GWAS-identified candidate genes associated with diapause regulation in Aedes albopictus across multiple life stages and ...

This project implements a complete end-to-end pipeline for analyzing RNA-Seq gene expression data to classify different cancer types. Using the PANCAN dataset from UCI Machine Learning Repository, we ...

mRNA Market Surges: The global mRNA market is booming, fueled by the success of COVID-19 vaccines, with applications expanding to cancer and genetic disorders. Driven by public-private investments, ...